JavaScript seem to be disabled in your browser.
You must have JavaScript enabled in your browser to utilize the functionality of this website.
Research Grade Cibisatamab is a bispecific humanized monoclonal antibody which targets Carcinoembryonic antigen-related cell adhesion molecule 5 & T-cell surface glycoprotein CD3 epsilon chain.